Physician profile
Benjamin Batchelor
NPI 1013043819
$1,165.41
in general payments reported to CMS, 2019-2025
17 companies · $299 in 2025
The $299 reported for 2025 was more than what 85% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $257 · 2022: $235 · 2023: $201 · 2024: $173 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $674.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $673.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $345.73 | 2021-2025 | Pediarix, Bexsero, Rotarix |
| Kowa Pharmaceuticals America, INC. | $125.00 | 2025 | Zoryve |
| Sanofi Pasteur INC. | $83.60 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $81.86 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Tris Pharma INC | $65.32 | 2021-2022 | |
| Pfizer INC. | $61.01 | 2021-2024 | |
| Corium, LLC | $55.25 | 2022-2025 | Azstarys |
| Kaleo, INC. | $53.75 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $43.65 | 2024-2025 | |
| Sobi, INC | $39.68 | 2023 | |
| Adlon Therapeutics L.P. | $36.96 | 2021 | |
| Ucb, INC. | $36.77 | 2024 | Briviact |
| Takeda Pharmaceuticals U.S.A., INC. | $36.63 | 2021-2025 | Elaprase |
| Astrazeneca Pharmaceuticals Lp | $35.50 | 2021-2023 | Flumist Quadrivalent |
| Ars Pharmaceuticals Operations, INC. | $27.78 | 2025 | Neffy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $20.17 | 2023 | Spinraza |
| Neos Therapeutics, Lp | $16.75 | 2024 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Batchelor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.